<p>AA Financial Advisors LLC 在最近向证券交易委员会（SEC）提交的 13F 文件中披露，在第二季度将其在礼来公司（NYSE:LLY - 免费报告）的持股比例降低了 26.6%。该机构投资者在此期间出售了 1,243 股后，持有该公司 3,427 股股票。截至其最近向证券交易委员会（SEC）提交的文件，AA Financial Advisors LLC 在礼来公司的持股价值为 2,671,000 美元。</p>
<p>获取 <strong>礼来公司</strong> 的提醒：</p>
<ul>
<li>礼来的口服 GLP-1 突破可能改变一切</li>
</ul>
<p>其他一些对冲基金最近也买卖了该股票的股份。Diversified Trust Co 在第二季度将其在礼来公司的持股比例提高了 1.3%。Diversified Trust Co 目前拥有 16,834 股该公司的股票，价值 13,123,000 美元，此前在上个季度又购买了 219 股。Assenagon Asset Management S.A. 在第二季度将其在礼来公司的股份提高了 106.8%。Assenagon Asset Management S.A. 目前拥有 1,481,031 股该公司的股票，价值 1,154,508,000 美元，此前在上个季度又收购了 765,010 股。Perpetual Ltd 在第二季度将其在礼来公司的股份提高了 7.1%。Perpetual Ltd 目前拥有 1,500 股该公司的股票，价值 1,169,000 美元，此前在上个季度又收购了 100 股。International Private Wealth Advisors LLC 在第二季度将其在礼来公司的股份提高了 40.1%。International Private Wealth Advisors LLC 目前拥有 1,676 股该公司的股票，价值 1,306,000 美元，此前在上个季度又收购了 480 股。最后，Livforsakringsbolaget Skandia Omsesidigt 在第二季度将其在礼来公司的股份提高了 17.9%。Livforsakringsbolaget Skandia Omsesidigt 目前拥有 27,706 股该公司的股票，价值 21,583,000 美元，此前在上个季度又收购了 4,200 股。机构投资者和对冲基金持有该公司 82.53% 的股份。</p>
<h2>礼来公司股价下跌 1.2%</h2>
<p>礼来公司的 LLY 股票周五开盘价为 753.52 美元。该公司的 50 日移动平均线为 738.37 美元，200 日移动平均线为 771.89 美元。礼来公司的 12 个月低点为 623.78 美元，12 个月高点为 939.86 美元。该公司的市值为 7131.8 亿美元，市盈率为 49.25，市盈增长比率为 1.06，贝塔值为 0.47。该公司的流动比率为 1.28，速动比率为 1.00，债务股本比率为 1.86。</p>
<ul>
<li>先锋集团的 VUG ETF：您投资组合的终极成长 ETF</li>
</ul>
<p>礼来公司（NYSE:LLY - 获取免费报告）最后一次公布财报是在 8 月 7 日星期四。该公司报告本季度每股收益为 6.31 美元，超出市场共识预期的 5.59 美元，超出幅度为 0.72 美元。礼来公司的股本回报率为 92.72%，净利润率为 25.91%。该公司本季度的收入为 155.6 亿美元，而市场共识预期为 144.0 亿美元。去年同期，该公司每股收益为 3.92 美元。该公司的收入同比增长 37.6%。礼来公司已将其 2025 财年的每股收益指导目标设定为 21.750-23.000 美元。股票分析师预测礼来公司本年度每股收益将达到 23.48 美元。</p>
<h2>礼来公司宣布分红</h2>
<p>该公司最近还宣布了一项季度分红，于 9 月 10 日星期三支付。8 月 15 日的登记投资者获得了 1.50 美元的分红。除息日为 8 月 15 日。这相当于年化 6.00 美元的分红，分红收益率为 0.8%。礼来公司的派息比率为 39.22%。</p>
<h2>礼来公司的内部交易</h2>
<ul>
<li>随着市场轮动，这只医疗保健 ETF 引领潮流</li>
</ul>
<p>在其他礼来公司的新闻中，首席执行官 David A. Ricks 于 8 月 12 日星期二购买了 1,632 股该公司的股票。每股平均购买价格为 644.77 美元，总交易额为 1,052,264.64 美元。完成购买后，首席执行官直接持有该公司 546,601 股股票，价值 352,431,926.77 美元。这代表其持股比例增加了 0.30%。该收购在向证券交易委员会提交的文件中披露，相关文件可通过此链接获取。此外，董事 Gabrielle Sulzberger 于 8 月 12 日星期二购买了 117 股该公司的股票。该股票的平均购买价格为 641.18 美元，总交易额为 75,018.06 美元。完成购买后，该董事持有该公司 2,703 股股票，价值约 1,733,109.54 美元。这代表其持股比例增加了 4.52%。该购买的披露信息可以在此找到。在过去的 90 天内，内部人士购买了价值 2,894,841 美元的 4,514 股公司股票。公司内部人士持有 0.13% 的股票。</p>
<h2>华尔街分析师预测增长</h2>
<p>几位股票研究分析师最近对 LLY 股票发表了看法。摩根大通将礼来公司的目标股价从 1,100.00 美元下调至 1,050.00 美元，并在周二的研究报告中对该股票给予了 “增持” 评级。Wall Street Zen 在周六的研究报告中将礼来公司的评级从 “强力买入” 下调至 “买入”。Berenberg Bank 在周三的研究报告中重申了 “持有” 评级，并将礼来公司的目标股价设定为 830.00 美元（之前为 970.00 美元）。瑞银集团在 8 月 8 日的研究报告中将礼来公司的目标股价从 1,050.00 美元下调至 895.00 美元，并对该股票给予了 “买入” 评级。最后，Leerink Partners 在 8 月 7 日的研究报告中将礼来公司的评级从 “强力买入” 下调至 “持有”。一位投资分析师对该股票给予了 “强力买入” 评级，十四位分析师给予了 “买入” 评级，九位分析师对该股票给予了 “持有” 评级。根据 MarketBeat 的数据，该公司目前的共识评级为 “适度买入”，共识目标股价为 939.61 美元。</p>
<p><strong>获取我们关于 LLY 的最新研究报告</strong></p>
<h2>礼来公司简介</h2>
<p>(免费报告)</p>
<p>礼来公司在全球范围内发现、开发和销售人用药物。该公司提供 Basaglar、Humalog、Humalog Mix 75/25、Humalog U-100、Humalog U-200、Humalog Mix 50/50、胰岛素 lispro、胰岛素 lispro 原料、胰岛素 lispro 混合 75/25、Humulin、Humulin 70/30、Humulin N、Humulin R 和 Humulin U-500 用于糖尿病；Jardiance、Mounjaro 和 Trulicity 用于 2 型糖尿病；Zepbound 用于肥胖。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更看好的股票，胜过礼来公司</li>
<li>什么是 WallStreetBets，他们关注哪些股票？</li>
<li>MarketBeat 周回顾 – 09/15 - 09/19</li>
<li>使用 MarketBeat 股息收益计算器</li>
<li>特斯拉：爱马斯克的 10 亿美元收购的两个理由，和一个看空的理由</li>
<li>什么是 MarketRank™？如何使用它</li>
<li>Azure 领先，而 AI 热潮推动微软股票</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxMWQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxMWQ"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在礼来公司吗？</h2>
<p>在考虑投资礼来公司之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前进行购买……而礼来公司并不在名单上。</p>
<p>虽然礼来公司目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

礼来

<p>AA Financial Advisors LLC 在第二季度减少了对礼来的持股比例，降幅为 26.6%，目前持有 3,427 股，市值为 267 万美元。其他对冲基金也调整了他们的持仓，其中 Assenagon Asset Management 和 Diversified Trust Co.的增持幅度显著。礼来的股票开盘价为 753.52 美元，市值为 7131.8 亿美元。公司报告第二季度每股收益为 6.31 美元，超出预期，并宣布季度股息为 1.50 美元。首席执行官 David A. Ricks 和董事 Gabrielle Sulzberger 最近进行了股票购买</p>

<p>AA Financial Advisors LLC lowered its stake in Eli Lilly and Company (NYSE:LLY - Free Report) by 26.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,427 shares of the company's stock after selling 1,243 shares during the period. AA Financial Advisors LLC's holdings in Eli Lilly and Company were worth $2,671,000 as of its most recent filing with the Securities and Exchange Commission (SEC).</p>
<div class="lb-trans"><p>AA Financial Advisors LLC 在最近向证券交易委员会（SEC）提交的 13F 文件中披露，在第二季度将其在礼来公司（NYSE:LLY - 免费报告）的持股比例降低了 26.6%。该机构投资者在此期间出售了 1,243 股后，持有该公司 3,427 股股票。截至其最近向证券交易委员会（SEC）提交的文件，AA Financial Advisors LLC 在礼来公司的持股价值为 2,671,000 美元。</p>
</div><p>Get <strong>Eli Lilly and Company</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>礼来公司</strong> 的提醒：</p>
</div><ul>
<li>Eli Lilly’s Oral GLP-1 Breakthrough Could Change Everything</li>
</ul>
<div class="lb-trans"><ul>
<li>礼来的口服 GLP-1 突破可能改变一切</li>
</ul>
</div><p>A number of other hedge funds also recently bought and sold shares of the stock. Diversified Trust Co raised its position in Eli Lilly and Company by 1.3% in the 2nd quarter. Diversified Trust Co now owns 16,834 shares of the company's stock valued at $13,123,000 after purchasing an additional 219 shares in the last quarter. Assenagon Asset Management S.A. raised its position in shares of Eli Lilly and Company by 106.8% during the 2nd quarter. Assenagon Asset Management S.A. now owns 1,481,031 shares of the company's stock worth $1,154,508,000 after acquiring an additional 765,010 shares in the last quarter. Perpetual Ltd raised its position in shares of Eli Lilly and Company by 7.1% during the 2nd quarter. Perpetual Ltd now owns 1,500 shares of the company's stock worth $1,169,000 after acquiring an additional 100 shares in the last quarter. International Private Wealth Advisors LLC raised its position in shares of Eli Lilly and Company by 40.1% during the 2nd quarter. International Private Wealth Advisors LLC now owns 1,676 shares of the company's stock worth $1,306,000 after acquiring an additional 480 shares in the last quarter. Finally, Livforsakringsbolaget Skandia Omsesidigt raised its position in shares of Eli Lilly and Company by 17.9% during the 2nd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 27,706 shares of the company's stock worth $21,583,000 after acquiring an additional 4,200 shares in the last quarter. Institutional investors and hedge funds own 82.53% of the company's stock.</p>
<div class="lb-trans"><p>其他一些对冲基金最近也买卖了该股票的股份。Diversified Trust Co 在第二季度将其在礼来公司的持股比例提高了 1.3%。Diversified Trust Co 目前拥有 16,834 股该公司的股票，价值 13,123,000 美元，此前在上个季度又购买了 219 股。Assenagon Asset Management S.A. 在第二季度将其在礼来公司的股份提高了 106.8%。Assenagon Asset Management S.A. 目前拥有 1,481,031 股该公司的股票，价值 1,154,508,000 美元，此前在上个季度又收购了 765,010 股。Perpetual Ltd 在第二季度将其在礼来公司的股份提高了 7.1%。Perpetual Ltd 目前拥有 1,500 股该公司的股票，价值 1,169,000 美元，此前在上个季度又收购了 100 股。International Private Wealth Advisors LLC 在第二季度将其在礼来公司的股份提高了 40.1%。International Private Wealth Advisors LLC 目前拥有 1,676 股该公司的股票，价值 1,306,000 美元，此前在上个季度又收购了 480 股。最后，Livforsakringsbolaget Skandia Omsesidigt 在第二季度将其在礼来公司的股份提高了 17.9%。Livforsakringsbolaget Skandia Omsesidigt 目前拥有 27,706 股该公司的股票，价值 21,583,000 美元，此前在上个季度又收购了 4,200 股。机构投资者和对冲基金持有该公司 82.53% 的股份。</p>
</div><h2>Eli Lilly and Company Trading Down 1.2%</h2>
<div class="lb-trans"><h2>礼来公司股价下跌 1.2%</h2>
</div><p>Shares of LLY stock opened at $753.52 on Friday. The business's 50 day moving average is $738.37 and its two-hundred day moving average is $771.89. Eli Lilly and Company has a twelve month low of $623.78 and a twelve month high of $939.86. The company has a market capitalization of $713.18 billion, a P/E ratio of 49.25, a price-to-earnings-growth ratio of 1.06 and a beta of 0.47. The company has a current ratio of 1.28, a quick ratio of 1.00 and a debt-to-equity ratio of 1.86.</p>
<div class="lb-trans"><p>礼来公司的 LLY 股票周五开盘价为 753.52 美元。该公司的 50 日移动平均线为 738.37 美元，200 日移动平均线为 771.89 美元。礼来公司的 12 个月低点为 623.78 美元，12 个月高点为 939.86 美元。该公司的市值为 7131.8 亿美元，市盈率为 49.25，市盈增长比率为 1.06，贝塔值为 0.47。该公司的流动比率为 1.28，速动比率为 1.00，债务股本比率为 1.86。</p>
</div><ul>
<li>Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio</li>
</ul>
<div class="lb-trans"><ul>
<li>先锋集团的 VUG ETF：您投资组合的终极成长 ETF</li>
</ul>
</div><p>Eli Lilly and Company (NYSE:LLY - Get Free Report) last announced its earnings results on Thursday, August 7th. The company reported $6.31 earnings per share for the quarter, beating the consensus estimate of $5.59 by $0.72. Eli Lilly and Company had a return on equity of 92.72% and a net margin of 25.91%.The company had revenue of $15.56 billion for the quarter, compared to the consensus estimate of $14.40 billion. During the same period last year, the business posted $3.92 EPS. The company's revenue was up 37.6% on a year-over-year basis. Eli Lilly and Company has set its FY 2025 guidance at 21.750-23.000 EPS. Equities analysts forecast that Eli Lilly and Company will post 23.48 EPS for the current year.</p>
<div class="lb-trans"><p>礼来公司（NYSE:LLY - 获取免费报告）最后一次公布财报是在 8 月 7 日星期四。该公司报告本季度每股收益为 6.31 美元，超出市场共识预期的 5.59 美元，超出幅度为 0.72 美元。礼来公司的股本回报率为 92.72%，净利润率为 25.91%。该公司本季度的收入为 155.6 亿美元，而市场共识预期为 144.0 亿美元。去年同期，该公司每股收益为 3.92 美元。该公司的收入同比增长 37.6%。礼来公司已将其 2025 财年的每股收益指导目标设定为 21.750-23.000 美元。股票分析师预测礼来公司本年度每股收益将达到 23.48 美元。</p>
</div><h2>Eli Lilly and Company Announces Dividend</h2>
<div class="lb-trans"><h2>礼来公司宣布分红</h2>
</div><p>The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 10th. Investors of record on Friday, August 15th were paid a $1.50 dividend. The ex-dividend date was Friday, August 15th. This represents a $6.00 dividend on an annualized basis and a dividend yield of 0.8%. Eli Lilly and Company's payout ratio is 39.22%.</p>
<div class="lb-trans"><p>该公司最近还宣布了一项季度分红，于 9 月 10 日星期三支付。8 月 15 日的登记投资者获得了 1.50 美元的分红。除息日为 8 月 15 日。这相当于年化 6.00 美元的分红，分红收益率为 0.8%。礼来公司的派息比率为 39.22%。</p>
</div><h2>Insider Transactions at Eli Lilly and Company</h2>
<div class="lb-trans"><h2>礼来公司的内部交易</h2>
</div><ul>
<li>As the Market Rotates, This Healthcare ETF Is Leading the Way</li>
</ul>
<div class="lb-trans"><ul>
<li>随着市场轮动，这只医疗保健 ETF 引领潮流</li>
</ul>
</div><p>In other Eli Lilly and Company news, CEO David A. Ricks purchased 1,632 shares of the firm's stock in a transaction that occurred on Tuesday, August 12th. The shares were purchased at an average cost of $644.77 per share, for a total transaction of $1,052,264.64. Following the completion of the purchase, the chief executive officer directly owned 546,601 shares in the company, valued at $352,431,926.77. This represents a 0.30% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available through this hyperlink. Also, Director Gabrielle Sulzberger purchased 117 shares of the firm's stock in a transaction that occurred on Tuesday, August 12th. The stock was acquired at an average price of $641.18 per share, for a total transaction of $75,018.06. Following the completion of the purchase, the director owned 2,703 shares of the company's stock, valued at approximately $1,733,109.54. This represents a 4.52% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders bought 4,514 shares of company stock valued at $2,894,841. 0.13% of the stock is owned by company insiders.</p>
<div class="lb-trans"><p>在其他礼来公司的新闻中，首席执行官 David A. Ricks 于 8 月 12 日星期二购买了 1,632 股该公司的股票。每股平均购买价格为 644.77 美元，总交易额为 1,052,264.64 美元。完成购买后，首席执行官直接持有该公司 546,601 股股票，价值 352,431,926.77 美元。这代表其持股比例增加了 0.30%。该收购在向证券交易委员会提交的文件中披露，相关文件可通过此链接获取。此外，董事 Gabrielle Sulzberger 于 8 月 12 日星期二购买了 117 股该公司的股票。该股票的平均购买价格为 641.18 美元，总交易额为 75,018.06 美元。完成购买后，该董事持有该公司 2,703 股股票，价值约 1,733,109.54 美元。这代表其持股比例增加了 4.52%。该购买的披露信息可以在此找到。在过去的 90 天内，内部人士购买了价值 2,894,841 美元的 4,514 股公司股票。公司内部人士持有 0.13% 的股票。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><p>Several equities research analysts have recently weighed in on LLY shares. JPMorgan Chase &amp; Co. cut their target price on Eli Lilly and Company from $1,100.00 to $1,050.00 and set an &#34;overweight&#34; rating on the stock in a research report on Tuesday. Wall Street Zen downgraded Eli Lilly and Company from a &#34;strong-buy&#34; rating to a &#34;buy&#34; rating in a research note on Saturday. Berenberg Bank restated a &#34;hold&#34; rating and set a $830.00 price target (down previously from $970.00) on shares of Eli Lilly and Company in a research note on Wednesday. UBS Group dropped their price target on Eli Lilly and Company from $1,050.00 to $895.00 and set a &#34;buy&#34; rating on the stock in a research note on Friday, August 8th. Finally, Leerink Partnrs downgraded Eli Lilly and Company from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research note on Thursday, August 7th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $939.61.</p>
<div class="lb-trans"><p>几位股票研究分析师最近对 LLY 股票发表了看法。摩根大通将礼来公司的目标股价从 1,100.00 美元下调至 1,050.00 美元，并在周二的研究报告中对该股票给予了 “增持” 评级。Wall Street Zen 在周六的研究报告中将礼来公司的评级从 “强力买入” 下调至 “买入”。Berenberg Bank 在周三的研究报告中重申了 “持有” 评级，并将礼来公司的目标股价设定为 830.00 美元（之前为 970.00 美元）。瑞银集团在 8 月 8 日的研究报告中将礼来公司的目标股价从 1,050.00 美元下调至 895.00 美元，并对该股票给予了 “买入” 评级。最后，Leerink Partners 在 8 月 7 日的研究报告中将礼来公司的评级从 “强力买入” 下调至 “持有”。一位投资分析师对该股票给予了 “强力买入” 评级，十四位分析师给予了 “买入” 评级，九位分析师对该股票给予了 “持有” 评级。根据 MarketBeat 的数据，该公司目前的共识评级为 “适度买入”，共识目标股价为 939.61 美元。</p>
</div><p><strong>Get Our Latest Research Report on LLY</strong></p>
<div class="lb-trans"><p><strong>获取我们关于 LLY 的最新研究报告</strong></p>
</div><h2>Eli Lilly and Company Profile</h2>
<div class="lb-trans"><h2>礼来公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免费报告)</p>
</div><p>Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.</p>
<div class="lb-trans"><p>礼来公司在全球范围内发现、开发和销售人用药物。该公司提供 Basaglar、Humalog、Humalog Mix 75/25、Humalog U-100、Humalog U-200、Humalog Mix 50/50、胰岛素 lispro、胰岛素 lispro 原料、胰岛素 lispro 混合 75/25、Humulin、Humulin 70/30、Humulin N、Humulin R 和 Humulin U-500 用于糖尿病；Jardiance、Mounjaro 和 Trulicity 用于 2 型糖尿病；Zepbound 用于肥胖。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Eli Lilly and Company</li>
<li>What Is WallStreetBets and What Stocks Are They Targeting?</li>
<li>MarketBeat Week in Review – 09/15 - 09/19</li>
<li>Using the MarketBeat Dividend Yield Calculator</li>
<li>Tesla: 2 Reasons to Love Musk's $1B Buy, 1 Reason to Be Bearish</li>
<li>What is MarketRank™? How to Use it</li>
<li>Azure Leads While AI Excitement Fuels Microsoft Stock</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过礼来公司</li>
<li>什么是 WallStreetBets，他们关注哪些股票？</li>
<li>MarketBeat 周回顾 – 09/15 - 09/19</li>
<li>使用 MarketBeat 股息收益计算器</li>
<li>特斯拉：爱马斯克的 10 亿美元收购的两个理由，和一个看空的理由</li>
<li>什么是 MarketRank™？如何使用它</li>
<li>Azure 领先，而 AI 热潮推动微软股票</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxMWQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=LLY"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Eli Lilly and Company Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在礼来公司吗？</h2>
</div><p>Before you consider Eli Lilly and Company, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑投资礼来公司之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前进行购买……而礼来公司并不在名单上。</p>
</div><p>While Eli Lilly and Company currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然礼来公司目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

AA Financial Advisors LLC 出售了礼来公司 $LLY 的股票